Though AI chatbots have potential in healthcare, they currently struggle with complex cancer treatments, reinforcing the essential role of human expertise. The fight against cancer is advancing, with innovations such as "universal" CAR T-cell therapy for blood cancers and the use of engineered bacteria for early cancer diagnosis. Risks are present in common practices, like alcohol consumption among cancer survivors or routine mammography in older women, underlining the need for increased awareness and personalized care. Atorvastatin may protect the heart during chemotherapy, and the FDA-approved Quizartinib benefits older AML patients. Germline testing and other research give hope in understanding cancer, its treatment, and prevention. However, the battle against cancer is ongoing, necessitating ceaseless research and innovation.
Full article here: https://medium.com/@lawsuithelpdesk/the-achilles-heel-of-ai-chatbots-struggle-with-cancer-treatment-information-a7c9fc80a020